期刊文献+

支气管肺泡细胞癌术后生存状况分析

Prognostic Analysis of 58 Patients with Bronchioalveolar Carcinoma
原文传递
导出
摘要 目的:探讨影响支气管肺泡细胞癌(BAC)预后的临床病理因素。方法:收集我科2003年1月~2008年12月所有手术治疗并经病理证实的58例BAC患者的临床资料,采用Life-tables、Kaplan-Meier、Log-rank和COX比例风险模型等统计学方法,对患者术后的生存状况进行评价分析。结果:Life-tables分析结果显示,患者1~5a生存率逐年降低,其中位生存时间为55.35月;Log-rank分析显示,肿瘤的大小、淋巴结的转移情况、TNM不同分期以及影像和病理学不同分型对于BAC患者生存率的影响差异有统计学意义(P〈0.05);肿瘤大小、TNM分期以及影像学和病理学分型是影响患者预后的独立危险因素。结论:肿瘤的大小、TNM分期以及影像学和病理学分型是影响BAC患者预后的独立危险因素;将BAC伴局部浸润和具有BAC特征的腺癌划为BAC值得商榷。 Objective: To investigate the clinicopathological factors associated with the prognosis of bronchioloalveolar carcinoma(BAC). Methods :58 BAC patients admitted our department from January, 2003 to December, 2008 were retrospectively analyzed. SPSS 13.0 software was used in Life - tables, Kaplan - Meier, Log - rank and COX regression analysis to analyze prognostic risk factors. Results: Lift - tables analysis confirmed the survival rate of 1 - 5 years decreased year by year, the median survival time(MST) was 55.35 months; Single survival analysis confirmed the survival was correlated to tumor size, lymph node, TNM stage, image typing and pathological typing, there were significant differences in the clinicopathological factors( P 〈 0.05 ). The results of multivariate analysis confirmed the tumor size, TNM stage, image and pathological typing were independent relevant factors. Conclusions:The tumor size, TNM stage, image and pathological typing were independent relevant factors to BAC patients ; It is debatable to regard the BAC with local invasion and the adenocarcinoma with characteristics of BAC as subtypes of BAC.
出处 《解剖与临床》 2012年第5期404-408,共5页 Anatomy and Clinics
关键词 肺癌 支气管肺泡细胞癌 预后 生存期 Lung cancer Bronchioloalveolar carcinoma Prognosis Survival
  • 相关文献

参考文献12

  • 1LiebowAA. Bronchiolo-alveolarcarcinoma[J].AdvInternMed,1960.329-358.
  • 2BrambillaE. Classificationofbroncho-pulmonarycancers(WHO1999)[J].Revue Des Maladies Respiratoires,2002,(04):455-466.
  • 3BeasleyMB,BrambillaE,TravisWD. The2004WorldHealthOr-ganizationclassificationoflungtumors[J].Seminars in Roentgenology,2005,(02):90-97.
  • 4WuYL,JiangGL,LuS. ChineseConsensusonBronchio-loalveolarCellCarcinoma[J].TheJournalofEvidence-BasedMedi-cine,2006,(04):227-229.
  • 5ArenbergD. BronchioloalveolarLungCancer:ACCPEvidence-BasedClinicalPracticeGuidelines(2ndEdition)[J].Chest,2007,(3suppl):306s-313s.
  • 6ReadWL,PageNC,TierneyRM. Theepidemiologyofbron-chioloalveolarcarcinomaoverthepastdecades:analysisoftheSE-ERdatabase[J].Lung Cancer,2004,(02):137-142.
  • 7GeNan,LiLong-yun,MiaoRuo-yu. Clinicalanalysisof184patientswithbronchioloalveolarcellcarcinoma[J].OncologyProgress,2008,(03):269-277.
  • 8ZellJA,OuSH,ZiogasA. Epidemiologyofbronchioloalveoncarcinoma:improvementinsurvivalafterreleaseofthe1999WHOclassificationoflungtumors[J].Journal of Clinical Oncology,2005,(33):8396-8405.
  • 9NoguchiM,MorikawaA,KawasakiM. Smalladenocarcino-maofthelung:Histologiccharacteristicsandprognosis[J].Cancer,1995,(12):2844-2852.
  • 10KoikeT,ToqashiK,ShiratoT. Limitedresectionfornonin-vasivebronchioloalveolarcarcinomadiagnosedbyintraoperativepathologicexamination[J].Annals of Thoracic Surgery,2009,(04):1106-1111.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部